Form 4: Cytek Biosciences Executive Valerie Barnett Reports Stock Transactions

Sentiment:

SEC Form 4


Valerie Barnett, Chief Legal Officer of Cytek Biosciences, reports the vesting of restricted stock units and subsequent tax withholding.

Summary

  • On May 19, 2025, Valerie Barnett, Chief Legal Officer of Cytek Biosciences, engaged in transactions involving Cytek Biosciences' common stock.
  • These transactions included the vesting of restricted stock units (RSUs) and the subsequent withholding of shares to cover tax obligations.
  • Barnett acquired shares through the vesting of RSUs and disposed of shares to satisfy tax withholding requirements at a price of $2.69 per share.
  • Following these transactions, Barnett directly owns 83,673 shares of Cytek Biosciences common stock and 166,763 derivative securities.

Sentiment

Score: 5

Explanation: This is a neutral report on stock transactions related to executive compensation.

Industry Context

This is a routine filing related to executive compensation and is typical for publicly traded companies.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they relate to executive compensation and do not significantly alter the company's financial position.

Key Dates

DateDescription
05/18/2022Initial vesting date for some of the Restricted Stock Units.
05/18/2023Vesting date for some of the Restricted Stock Units.
08/18/2023Vesting date for some of the Restricted Stock Units.
11/18/2023Vesting date for some of the Restricted Stock Units.
03/10/2024Vesting date for some of the Restricted Stock Units.
05/18/2024Vesting date for some of the Restricted Stock Units.
08/18/2024Vesting date for some of the Restricted Stock Units.
11/18/2024Vesting date for some of the Restricted Stock Units.
03/10/2025Vesting date for some of the Restricted Stock Units.
05/19/2025Date of the reported transactions: vesting of RSUs and tax withholding.
05/18/2025Vesting date for some of the Restricted Stock Units.
08/18/2025Vesting date for some of the Restricted Stock Units.
11/18/2025Vesting date for some of the Restricted Stock Units.
03/10/2026Vesting date for some of the Restricted Stock Units.
05/21/2025Date of the form filing.

Keywords

Cytek Biosciences, Valerie Barnett, Form 4, Stock Transactions, Restricted Stock Units, RSU, Tax Withholding, Beneficial Ownership, CTKB

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.